Zhiping Zhang

Nanchang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Circulating Metabolic Factors Mediating the Effect of Obesity-Related Indicators on Meniscal Injuries: A Mendelian Randomization Study.

Circulating Metabolic Factors Mediating the Effect of Obesity-Related Indicators on Meniscal Injuries: A Mendelian Randomization Study.

Journal: International journal of genomics
Published: December 17, 2025

SMPD1 modulates malignant progress of osteosarcoma through ferroptosis pathway.

SMPD1 modulates malignant progress of osteosarcoma through ferroptosis pathway.

Journal: Tissue & cell
Published: October 11, 2025

DLST mediates the malignant progression of osteosarcoma cells by regulating the p38 MAPK signaling pathway.

DLST mediates the malignant progression of osteosarcoma cells by regulating the p38 MAPK signaling pathway.

Journal: Biochemical and biophysical research communications
Published: September 25, 2025

PTEN and GATA3 as Key Molecular Mediators Linking Diabetes Mellitus to Osteoarthritis: A Comprehensive Mendelian Randomization, Bioinformatics, and Experimental Study.

PTEN and GATA3 as Key Molecular Mediators Linking Diabetes Mellitus to Osteoarthritis: A Comprehensive Mendelian Randomization, Bioinformatics, and Experimental Study.

Journal: International journal of endocrinology
Published: March 24, 2025

Graphene Oxide Functionalized GelMA Platform Loaded With BFP-1 for Osteogenic Differentiation of BMSCs.

Graphene Oxide Functionalized GelMA Platform Loaded With BFP-1 for Osteogenic Differentiation of BMSCs.

Journal: Journal of biomedical materials research. Part A
Published: July 26, 2024

Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells.

Solute carrier family 35 member A2 regulates mitophagy through the PI3K/AKT/mTOR axis, promoting the proliferation, migration, and invasion of osteosarcoma cells.

Journal: Gene
Published: October 22, 2023

LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.

LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.

Journal: BMC cancer
Published: October 10, 2023

LncRNA GClnc1 promotes osteosarcoma progression by stabilizing NONO and blocking FBXW7-mediated ubiquitination.

LncRNA GClnc1 promotes osteosarcoma progression by stabilizing NONO and blocking FBXW7-mediated ubiquitination.

Journal: BMC cancer
Published: July 24, 2023

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.

Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.

Journal: Cell death & disease
Published: December 30, 2021

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma.

Serglycin promotes proliferation, migration, and invasion via the JAK/STAT signaling pathway in osteosarcoma.

Journal: Aging
Published: February 02, 2021

Role of LncRNAs in regulating cancer amino acid metabolism.

Role of LncRNAs in regulating cancer amino acid metabolism.

Journal: Cancer cell international
Published: January 29, 2021

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU.

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU.

Journal: Bioscience reports
Published: November 25, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026